Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-21-008212
Filing Date
2021-04-05
Accepted
2021-04-05 16:05:21
Documents
4
Period of Report
2021-05-14

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A atos20210330_pre14a.htm PRE 14A 320164
2 logo.jpg GRAPHIC 11185
3 proxy.jpg GRAPHIC 245394
4 sig.jpg GRAPHIC 6165
  Complete submission text file 0001437749-21-008212.txt   677830
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35610 | Film No.: 21805340
SIC: 2834 Pharmaceutical Preparations